These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15570001)

  • 21. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
    Huo MR; Zhou JP; Wei Y; Lü L
    Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW
    Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion.
    Huang CY; Chen CM; Lee YD
    Int J Pharm; 2007 Jun; 338(1-2):267-75. PubMed ID: 17368981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine.
    Gao X; Au JL; Badalament RA; Wientjes MG
    Clin Cancer Res; 1998 Jan; 4(1):139-43. PubMed ID: 9516962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
    Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
    BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder wall penetration of intravesical mitomycin C in dogs.
    Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.
    Nornoo AO; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):117-23. PubMed ID: 17869458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Lee MK; Lim SJ; Kim CK
    Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
    Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
    Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
    Jin C; Bai L; Wu H; Tian F; Guo G
    Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
    Mo Y; Lim LY
    J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.
    Sawant RR; Torchilin VP
    Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
    Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
    Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer.
    Chu H; Liu N; Wang X; Jiao Z; Chen Z
    Int J Pharm; 2009 Apr; 371(1-2):190-6. PubMed ID: 19162151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO; Osborne DW; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.